| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/12/2002 | EP1212317A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 06/12/2002 | EP1212316A2 Benzopyrans and benzothiopyrans as rar selective retinoid agonists |
| 06/12/2002 | EP1212313A1 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 06/12/2002 | EP1212312A1 Novel derivatives of flavones, xanthones and coumarins |
| 06/12/2002 | EP1212309A1 Caspase inhibitor |
| 06/12/2002 | EP1212306A2 Hydroxyalkanoylaminolactams and related structures as inhibitors of abeta protein production |
| 06/12/2002 | EP1212305A2 1,5-benzodiazepine derivatives as cck-a receptor agonists |
| 06/12/2002 | EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 06/12/2002 | EP1212300A1 Azacycloalkanone serine protease inhibitors |
| 06/12/2002 | EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/12/2002 | EP1212298A1 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine |
| 06/12/2002 | EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 06/12/2002 | EP1212295A1 SUBSTITUTED $g(a)-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 06/12/2002 | EP1212099A2 Amphiphilic prodrugs |
| 06/12/2002 | EP1212098A2 Enzyme inhibitors |
| 06/12/2002 | EP1212097A2 Enzyme inhibitors |
| 06/12/2002 | EP1212089A2 Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonists |
| 06/12/2002 | EP1212087A1 Methods and compositions utilizing rad51 |
| 06/12/2002 | EP1212085A2 Compositions for stimulating cytokine secretion and inducing an immune response |
| 06/12/2002 | EP1212081A2 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 06/12/2002 | EP1212070A1 Plant extract mixtures and their uses |
| 06/12/2002 | EP1212068A1 Method of enhancing the efficacy of anti-tumor agents |
| 06/12/2002 | EP1212067A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 06/12/2002 | EP1212065A1 Compositions and methods for raising hdl cholesterol levels |
| 06/12/2002 | EP1212063A2 Topical azathioprine for the treatment of oral autoimmune diseases |
| 06/12/2002 | EP1212062A1 Use of thienopyrimidines |
| 06/12/2002 | EP1212059A1 Iron chelators and uses thereof |
| 06/12/2002 | EP1212057A1 Extended duration light activated cancer therapy |
| 06/12/2002 | EP1212055A1 Neurotherapeutic composition and method |
| 06/12/2002 | EP1212052A2 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 06/12/2002 | EP1212041A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 06/12/2002 | EP1212034A1 Enzyme inhibitors |
| 06/12/2002 | EP1212000A1 Method of controlling body temperature while reducing shivering |
| 06/12/2002 | EP1211931A1 A knockout mouse for the tumor suppressor gene anx7 |
| 06/12/2002 | EP1056722B1 Bisulfate salt of hiv protease inhibitor |
| 06/12/2002 | EP1039922B1 Improved interferon polymer conjugates |
| 06/12/2002 | EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 06/12/2002 | EP1023287B1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors |
| 06/12/2002 | EP1005337A4 Pharmacologic drug combination in vagal-induced asystole |
| 06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
| 06/12/2002 | EP0966437B1 5-aroylnaphthalene derivatives |
| 06/12/2002 | EP0929517B1 Hydroxamic acid derivatives |
| 06/12/2002 | EP0888327B1 Benzopyran derivatives having leukotriene-antagonistic action |
| 06/12/2002 | EP0885210B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
| 06/12/2002 | EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP0880540B1 17-beta-cyclopropyl(amino/oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20-lyase |
| 06/12/2002 | EP0873320B1 Piperazine derivatives as tachykinin antagonists |
| 06/12/2002 | EP0873312B1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/12/2002 | EP0776324B1 Endothelin antagonists |
| 06/12/2002 | EP0768881B1 Anti-hiv triple combination comprising zidovudine, lamivudine and loviride |
| 06/12/2002 | EP0751939B1 Naphthylamides as central nervous system agents |
| 06/12/2002 | EP0751778B1 Use of deuterium-depleted water for preparing hygienic and cosmetic preparations |
| 06/12/2002 | EP0737200B1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 06/12/2002 | EP0734391B1 Pna-dna-pna chimeric macromolecules |
| 06/12/2002 | EP0734259B1 Use of piperidine compounds in the treatment of schizophrenia |
| 06/12/2002 | EP0730460B1 The use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | EP0652867B1 Novel pyridyl- and pyrimidylpiperazine derivatives |
| 06/12/2002 | EP0460062B1 Huperzine a analogs |
| 06/12/2002 | CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway |
| 06/12/2002 | CN1353713A Purine inhibitors of cyclin dependent kinase 2 and IK B-alpha |
| 06/12/2002 | CN1353712A Polymorphs of crystalline (2-benzhydryl-2-azabicyclo [2.2.2] OCT-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as NK-1 receptor antagonists |
| 06/12/2002 | CN1353710A 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 06/12/2002 | CN1353705A Pyrazinone thrombin inhibitors |
| 06/12/2002 | CN1353704A 取代吡唑化合物 A substituted pyrazole compound |
| 06/12/2002 | CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 06/12/2002 | CN1353697A 4-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353696A 5-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof |
| 06/12/2002 | CN1353694A Alpha-substituted carboxylic acid derivatives |
| 06/12/2002 | CN1353692A Betz 2-adrenoceptor agonists |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353689A 新的异羟肟酸衍生物 The new hydroxamic acid derivatives |
| 06/12/2002 | CN1353684A Ether compounds, compositions, and uses thereof |
| 06/12/2002 | CN1353613A Pharmaceutical compositions |
| 06/12/2002 | CN1353612A Tanacetum parthenium extract |
| 06/12/2002 | CN1353609A Amide substituted imidazoquinolines |
| 06/12/2002 | CN1353607A Improved pharmaceutical formulations |
| 06/12/2002 | CN1353606A IL-8 receptor antagonists |
| 06/12/2002 | CN1353605A Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and use thereof |
| 06/12/2002 | CN1353604A New use of modafinil and D/L enantiomer |
| 06/12/2002 | CN1353573A Anti-inflammatory therapy for inflammatory mediated infection |
| 06/12/2002 | CN1352990A Bio-active substance of antrodia camphorata mycelia, its preparing process and its composition |
| 06/12/2002 | CN1352982A Enterior-applied Chinese medicine 'Shutonghuaaiping' for treating cerebroma and hydrocephalus |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403810 Thiophene derivatives |
| 06/11/2002 | US6403799 Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors |
| 06/11/2002 | US6403792 Sulfonyl isatin compounds and methods of blocking apoptosis therewith |
| 06/11/2002 | US6403791 Treatment of inflammatory diseases or autoimmune diseases in humans or animals |
| 06/11/2002 | US6403790 Suspending and dissolving epinastine base in water by adding aqueous hydrochloric acid at specified ph, extracting solution obtained with organic water-immiscible solvent, removing solvent, adjusting ph to precipitate product, drying |
| 06/11/2002 | US6403656 Skin disorders |
| 06/11/2002 | US6403650 Treatment of pulmonary hypertension |
| 06/11/2002 | US6403638 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 06/11/2002 | US6403636 Xanthone compounds, their preparation and use as medicament |
| 06/11/2002 | US6403614 Such as 2-(4-(methylthiomethoxy)phenyl)-3-(4-(2-piperidin-1-yl)ethoxy) benzoyl)-6-methylthiomethoxybenzo(b)thiophene;inhibition of osteoporosis, hyperlipedemia, cancer, postmenopausal syndrome, |
| 06/11/2002 | US6403613 Anti-inflammatory agent that reduces levels of cytokines (including tumor necrosis factor) |
| 06/11/2002 | US6403611 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | US6403601 N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (NK1) and/or neurokinin 2 (NK2) receptor antagonists |
| 06/11/2002 | US6403599 Corticotropin releasing factor antagonists |